Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Voliotis Dimitris
SVP, Clinical Development at Zentalis Pharmaceuticals. Filing since 18 Jan 2022.
CIK 0001807910
Company
Date
Role
Action
Shares
Amount
Of holding
ZNTL
Zentalis Pharmaceuticals, Inc.
14 Feb 2022
SVP, Clinical Development
Sold, plan not stated
601
$30.19K
3.6%
ZNTL
Zentalis Pharmaceuticals, Inc.
20 Jan 2022
SVP, Clinical Development
Sold, plan not stated
10,000
$606.32K
61.5%
ZNTL
Zentalis Pharmaceuticals, Inc.
19 Jan 2022
SVP, Clinical Development
Sold, plan not stated
10,000
$607.93K
61.5%
ZNTL
Zentalis Pharmaceuticals, Inc.
18 Jan 2022
SVP, Clinical Development
Sold, plan not stated
10,000
$626.49K
61.5%
4 decisions on file.
